Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9609 posts found.

Belharra Therapeutics and Genentech join forces for small molecule medicine development

January 5, 2023 Research and Development

US-based biotech companies Belharra Therapeutics and Genentech have announced a multi-year partnership to lead the discovery and development of small …
News

Biogen and Alcyone Therapeutics enter partnership to develop ThecaFlex DRx system for ASO therapies

January 5, 2023 Research and Development

US-based Biogen and Alcyone Therapeutics have entered into a license and collaboration agreement to develop Alcyone’s ThecaFlex DRx™ System.   …
News

Rare cancer drug for young patients approved

January 3, 2023 Research and Development

A new treatment option for adult and paediatric patients with a rare soft tissue cancer has been approved. The FDA …
News

Abiomed receives FDA approval for heart pump clinical trial

December 22, 2022 Research and Development

Abiomed, a leading provider of medical technology focusing on the circulatory system and oxygenation, has announced that the FDA has …
News

Idorsia submits new drug application to FDA for aprocitentan to treat difficult-to-control hypertension

December 20, 2022 Research and Development

Idorsia has announced that it has submitted a new drug application (NDA) to the FDA in hopes of gaining approval …
News

AlzeCure has abstract accepted on possible disease-modifying effects of ACD856 against Alzheimer’s

December 20, 2022 Research and Development

AlzeCure, a pharma company who focuses on its portfolio of small molecule candidate drugs for central nervous system (CNS) diseases, …
News

New study shares effectiveness of asthma drug compared to standard of care

December 19, 2022 Research and Development

The University of Plymouth has co-authored a new study, published in The Lancet, which shows how an asthma drug, commercially …
News

Targeted imaging agent for lung cancer surgery approved by FDA

December 19, 2022 Research and Development

The FDA has approved Cytalux (pafolacianine) to be used in lung cancer surgery: the targeted imaging agent binds to cancerous …
News

CDC provides $12.5m grant to study real-world effectiveness of vaccines

December 16, 2022 Research and Development

The Center for Disease Control and Prevention (CDC) has given researchers at Washington University School of Medicine in St Louis, …
News

New blood test appears to detect hidden cancer

December 16, 2022 Research and Development

Biotech company Guardant Health has announced that its blood test-based cancer screening technique appears to be effective: the liquid biopsy …
News

Merck and Moderna’s mRNA cancer vaccine is successful in efficacy trial

December 14, 2022 Research and Development

Merck & Co and Moderna have partnered to utilise the mRNA technology used to combat COVID-19, however this time the …
News

ClearPoint recruits first patient in laser therapy study to treat Glioblastoma

December 14, 2022 Research and Development

California, US-based ClearPoint Neuro has recruited the first patient in a clinical trial which will use ClearPoint’s Prism Neuro Laser …
News

AI model predicts CVD risk from single chest radiograph

December 14, 2022 Research and Development

A recently-developed AI model has been shown to predict ten-year incidences with a similar level of success to the current …
News

Autolus announces positive primary endpoint data in FELIX trial

December 13, 2022 Research and Development

Autolus Therapeutic, a clinical-stage biopharmaceutical company, has announced that the phase 2 FELIX clinical trial of obecabtagene autoleucel (obe-cel) in …
News

Seagen shares data for Adcetris combination for Hodgkin Lymphoma

December 13, 2022 Research and Development

Adcetris has long been one of Seagen’s top-selling and expanding products, and it has announced that the drug appeared successful …
News
The Gateway to Local Adoption Series

Latest content

Sandoz launches allergy relief nasal spray in Germany and Switzerland

April 9, 2026

Japan approve Daiichi Sankyo’s Enhertu as a second-line treatment for gastric cancer

April 9, 2026

Trelleborg to take part in Medtec Japan 2026

April 8, 2026

Kainova Therapeutics expands phase I/II trial of antibody drug

April 7, 2026

Eisai starts enrolment for phase 2 narcolepsy study evaluating E2086

April 7, 2026